1. Procalcitonin (PCT) level in the emergency department identifies a high-risk cohort for all patients treated for possible sepsisGeorgia Lucas, Angela Bartolf, Nicholas Kroll, Agampodi-Umanda De Thabrew, Zoya Murtaza, Siddarth Kumar, Abrar Gani, Andrea Annoni, Marie Parsons, Helen Pardoe
  2. Reducing patient risk and enhancing care through the development and implementation of a new chest pain pathway, expedited by and for the COVID-19 eraMartin P. Than, John W. Pickering, Philip Adamson, Thomas Clendon, Christopher M. Florkowski, John Lainchbury, Jacques Loubser, Alison Nankivel, Sally J. Aldous
  3. The Kidney Check program – championing patient-centered, culturally safe, preventive kidney care in Canada’s rural and remote Indigenous communitiesSarah Curtis, David Collister, Heather Martin, AbdulRazaq Sokoro, Lorraine McLeod, Caroline Chartrand, Barry Lavallee, Cathy Woods, Adeera Levin, Paul Komenda
  4. Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreakAnna Ferrari, Fabian Sanchis-Gomar, Camilla Mattiuzzi, Brandon M. Henry, Giuseppe Lippi
  5. E-gene RT-PCR crossing point value and other biochemical parameters as useful markers of death risk in COVID-19 patientsAlba Bellés-Bellés, María Bernal, Javier Gómez-Arbonés, Albert Bernet, Silvia Picó, Jessica Bueno, Carlos Chávez, Mercè García-González, Mercè Ibarz
  6. Diabetic euglycemic ketoacidosis induced by oral antidiabetics type SGLT2iGuillermo Velasco de Cos, María Isabel Sánchez-Molina Acosta, María Matilde Toval Fernández

Copyright © 1999-2024 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved.

Contents may not be reproduced without the prior permission of the Communications and Publications Division (CPD) of the IFCC.